Literature DB >> 15800652

Assessment of sexual functions in patients with chronic liver disease.

I Simsek1, G Aslan, M Akarsu, H Koseoglu, A Esen.   

Abstract

We aimed to determine the sexual problems and the prevalence of erectile dysfunction (ED) in patients with chronic liver disease by means of International Index of Erectile Function (IIEF). A total of 81 patients with stable chronic liver disease were included in the study. Patients were grouped as mild to moderate (Child Pugh A and B) (n=10), chronic hepatitis (hepatitis B, C and D) (n=28) and carriers (n=43) according to the type of their chronic liver disease. All patients were asked to complete a questionnaire including IIEF and demographics. The IIEF domain scores were calculated and ED grading was determined on erectile function domain. IIEF domain scores were compared between these groups. The mean age was 54.8 +/- 10.8 y. Using the IIEF, the prevalence of any ED was 50.6% for all patients, and 50, 50, and 51.1% for cirrhosis, chronic hepatitis and carriers, respectively. The IIEF domain scores were not significantly different among the patient groups. Sexual functions did not appear to be affected by the stable chronic liver disease.

Entities:  

Mesh:

Year:  2005        PMID: 15800652     DOI: 10.1038/sj.ijir.3901316

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  13 in total

Review 1.  Male sexual disturbances in liver diseases: what do we know?

Authors:  M Durazzo; A Premoli; C Di Bisceglie; S Bo; E Ghigo; C Manieri
Journal:  J Endocrinol Invest       Date:  2010 Jul-Aug       Impact factor: 4.256

2.  Symptom distress in patients with end-stage liver disease toward the end of life.

Authors:  Lissi Hansen; Michael C Leo; Michael F Chang; Atif Zaman; Willscott Naugler; Jonathan Schwartz
Journal:  Gastroenterol Nurs       Date:  2015 May-Jun       Impact factor: 0.978

3.  Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment.

Authors:  Anhye Kim; Jongtae Lee; Donghoon Shin; Yong Jin Jung; Mi Young Bahng; Joo-Youn Cho; In-Jin Jang
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

4.  Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease.

Authors:  Serhat Bor; Elen Valytova; Suna Yapali; Esra Yildirim; Rukiye Vardar
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

5.  Association of erectile dysfunction with depression in patients with chronic viral hepatitis.

Authors:  Bong Oh Ma; Sang Goon Shim; Hae Jin Yang
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

6.  Prevalence and risk factors of erectile dysfunction in patients with liver cirrhosis: a systematic review and meta-analysis.

Authors:  Hye Jin Yoo; Bora Lee; Eun-Ae Jung; Sang Gyune Kim; Young Seok Kim; Jeong-Ju Yoo
Journal:  Hepatol Int       Date:  2021-11-20       Impact factor: 6.047

7.  Does Treatment of Erectile Dysfunction With PDE 5 Inhibitor Tadalafil Improve Quality of Life in Male Patients With Compensated Chronic Liver Disease? A Prospective Pilot Study.

Authors:  Alok Kumar; Vivek Saraswat; Gaurav Pande; Rajesh Kumar
Journal:  J Clin Exp Hepatol       Date:  2022-01-23

8.  Erectile Dysfunction in Cirrhosis: Its Prevalence and Risk Factors.

Authors:  Rakesh K Jagdish; Ahmed Kamaal; Saggere M Shasthry; Jaya Benjamin; Rakhi Maiwall; Ankur Jindal; Ashok Choudhary; Vijayaraghavan Rajan; Vinod Arora; Ankit Bhardwaj; Guresh Kumar; Manoj Kumar; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2022-05-10

Review 9.  Male hypogonadism in cirrhosis and after liver transplantation.

Authors:  C Foresta; M Schipilliti; F A Ciarleglio; A Lenzi; D D'Amico
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

10.  Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.

Authors:  Jitender Thakur; Sahaj Rathi; Sandeep Grover; Madhu Chopra; Swastik Agrawal; Sunil Taneja; Ajay Duseja; Anil Bhansali; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2018-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.